Viewing Study NCT03637361


Ignite Creation Date: 2025-12-24 @ 12:17 PM
Ignite Modification Date: 2026-01-06 @ 7:56 AM
Study NCT ID: NCT03637361
Status: COMPLETED
Last Update Posted: 2019-08-01
First Post: 2018-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone)
Sponsor: Relmada Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module